Charles Wilson - Net Worth and Insider Trading

Charles Wilson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles Wilson owns 4 companies in total, including Cogent Biosciences Inc (COGT) , Ignyte Acquisition Corp (IGNYU) , and Ignyte Acquisition Corp (IGNY) among others .

Click here to see the complete history of Charles Wilson’s form 4 insider trades.

Insider Ownership Summary of Charles Wilson

Ticker	Comapny	Transaction Date	Type of Owner
COGT	Cogent Biosciences Inc	2018-03-28	director & Chief Executive Officer
IGNYU	Ignyte Acquisition Corp	2021-01-27	director
IGNY	Ignyte Acquisition Corp	2021-01-27	director
		2021-01-27	director

Charles Wilson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles Wilson Ownership Network

Ownership Network List of Charles Wilson

No Data

Ownership Network Relation of Charles Wilson

Charles Wilson Owned Company Details

What does Cogent Biosciences Inc do?

Who are the key executives at Cogent Biosciences Inc?

Charles Wilson is the director & Chief Executive Officer of Cogent Biosciences Inc. Other key executives at Cogent Biosciences Inc include 10 percent owner & other: See Remarks Fairmount Funds Management Llc , Chief Legal Officer Evan Kearns , and Chief Financial Officer John L. Green .

Cogent Biosciences Inc (COGT) Insider Trades Summary

Over the past 18 months, Charles Wilson made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cogent Biosciences Inc Insider Transactions

No Available Data

What does Ignyte Acquisition Corp do?

Who are the key executives at Ignyte Acquisition Corp?

Charles Wilson is the director of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Ignyte Acquisition Corp (IGNYU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyte Acquisition Corp Insider Transactions

No Available Data

What does Ignyte Acquisition Corp do?

Who are the key executives at Ignyte Acquisition Corp?

Charles Wilson is the director of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include 10 percent owner Ignyte Sponsor Llc , director & 10 percent owner & Co-Chief Executive Officer David I. Rosenberg , and director & 10 percent owner & Co-Chief Executive Officer David J. Strupp .

Ignyte Acquisition Corp (IGNY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyte Acquisition Corp Insider Transactions

No Available Data

What does Peak Bio Inc do?

Who are the key executives at Peak Bio Inc?

Charles Wilson is the director of Peak Bio Inc. Other key executives at Peak Bio Inc include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Peak Bio Inc (PKBO) Insider Trades Summary

Over the past 18 months, Charles Wilson made no insider transaction in Peak Bio Inc (PKBO). Other recent insider transactions involving Peak Bio Inc (PKBO) include a net purchase of 190,250 shares made by Hoyoung Huh ,

In summary, during the past 3 months, insiders sold 0 shares of Peak Bio Inc (PKBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Peak Bio Inc (PKBO) were sold and 190,250 shares were bought by its insiders, resulting in a net purchase of 190,250 shares.

Peak Bio Inc (PKBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Peak Bio Inc Insider Transactions

No Available Data

Charles Wilson Mailing Address

Above is the net worth, insider trading, and ownership report for Charles Wilson. You might contact Charles Wilson via mailing address: C/o Unum Therapeutics, 200 Cambridgepark Dr., Ste. 3100, Cambridge Ma 02140.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.